Brandon Couillard
Stock Analyst at Wells Fargo
(4.67)
# 168
Out of 5,090 analysts
161
Total ratings
66.33%
Success rate
18.97%
Average return
Main Sectors:
Stocks Rated by Brandon Couillard
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BLLN BillionToOne | Initiates: Equal-Weight | $110 | $108.06 | +1.80% | 1 | Dec 1, 2025 | |
| A Agilent Technologies | Maintains: Overweight | $150 → $175 | $145.82 | +20.01% | 25 | Nov 25, 2025 | |
| EXAS Exact Sciences | Downgrades: Hold | $90 → $105 | $101.18 | +3.78% | 19 | Nov 24, 2025 | |
| MTD Mettler-Toledo International | Maintains: Equal-Weight | $1,200 → $1,400 | $1,416.28 | -1.15% | 6 | Nov 10, 2025 | |
| NTRA Natera | Maintains: Equal-Weight | $175 → $190 | $243.99 | -22.13% | 2 | Nov 7, 2025 | |
| TECH Bio-Techne | Maintains: Overweight | $59 → $70 | $62.54 | +11.93% | 2 | Nov 6, 2025 | |
| WAT Waters | Maintains: Equal-Weight | $315 → $385 | $396.12 | -2.81% | 6 | Nov 5, 2025 | |
| BRKR Bruker | Maintains: Overweight | $50 → $48 | $47.59 | +0.86% | 6 | Nov 5, 2025 | |
| MYGN Myriad Genetics | Maintains: Equal-Weight | $6 → $6.5 | $7.13 | -8.77% | 3 | Nov 5, 2025 | |
| WGS GeneDx Holdings | Maintains: Equal-Weight | $95 → $140 | $158.80 | -11.84% | 5 | Nov 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $265 → $340 | $318.50 | +6.75% | 13 | Oct 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $265 → $340 | $318.35 | +6.80% | 13 | Oct 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $565 → $635 | $573.12 | +10.80% | 7 | Oct 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $205 → $230 | $227.11 | +1.27% | 4 | Oct 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $72 | $102.87 | -30.01% | 1 | Sep 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $19 → $14 | $18.54 | -24.49% | 3 | Aug 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Equal-Weight | $100 → $67 | $77.19 | -13.20% | 3 | Aug 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $19 → $16 | $11.04 | +44.99% | 5 | Aug 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $180 → $175 | $165.28 | +5.88% | 2 | Jul 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $130 → $102 | $101.40 | +0.59% | 2 | Apr 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $285 → $260 | $157.65 | +64.92% | 11 | Jan 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $77 → $80 | $73.64 | +8.64% | 6 | Jan 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $10 | $3.71 | +169.54% | 1 | Aug 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $30 → $23 | $20.26 | +13.52% | 1 | Feb 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $13 | $1.98 | +558.23% | 1 | Jul 13, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $2.48 | - | 11 | Nov 2, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $9 → $11 | $1.77 | +521.47% | 2 | Oct 13, 2017 |
BillionToOne
Dec 1, 2025
Initiates: Equal-Weight
Price Target: $110
Current: $108.06
Upside: +1.80%
Agilent Technologies
Nov 25, 2025
Maintains: Overweight
Price Target: $150 → $175
Current: $145.82
Upside: +20.01%
Exact Sciences
Nov 24, 2025
Downgrades: Hold
Price Target: $90 → $105
Current: $101.18
Upside: +3.78%
Mettler-Toledo International
Nov 10, 2025
Maintains: Equal-Weight
Price Target: $1,200 → $1,400
Current: $1,416.28
Upside: -1.15%
Natera
Nov 7, 2025
Maintains: Equal-Weight
Price Target: $175 → $190
Current: $243.99
Upside: -22.13%
Bio-Techne
Nov 6, 2025
Maintains: Overweight
Price Target: $59 → $70
Current: $62.54
Upside: +11.93%
Waters
Nov 5, 2025
Maintains: Equal-Weight
Price Target: $315 → $385
Current: $396.12
Upside: -2.81%
Bruker
Nov 5, 2025
Maintains: Overweight
Price Target: $50 → $48
Current: $47.59
Upside: +0.86%
Myriad Genetics
Nov 5, 2025
Maintains: Equal-Weight
Price Target: $6 → $6.5
Current: $7.13
Upside: -8.77%
GeneDx Holdings
Nov 4, 2025
Maintains: Equal-Weight
Price Target: $95 → $140
Current: $158.80
Upside: -11.84%
Oct 30, 2025
Maintains: Equal-Weight
Price Target: $265 → $340
Current: $318.50
Upside: +6.75%
Oct 30, 2025
Maintains: Equal-Weight
Price Target: $265 → $340
Current: $318.35
Upside: +6.80%
Oct 23, 2025
Maintains: Overweight
Price Target: $565 → $635
Current: $573.12
Upside: +10.80%
Oct 23, 2025
Maintains: Equal-Weight
Price Target: $205 → $230
Current: $227.11
Upside: +1.27%
Sep 22, 2025
Initiates: Overweight
Price Target: $72
Current: $102.87
Upside: -30.01%
Aug 8, 2025
Maintains: Equal-Weight
Price Target: $19 → $14
Current: $18.54
Upside: -24.49%
Aug 8, 2025
Upgrades: Equal-Weight
Price Target: $100 → $67
Current: $77.19
Upside: -13.20%
Aug 4, 2025
Maintains: Overweight
Price Target: $19 → $16
Current: $11.04
Upside: +44.99%
Jul 30, 2025
Maintains: Overweight
Price Target: $180 → $175
Current: $165.28
Upside: +5.88%
Apr 17, 2025
Maintains: Equal-Weight
Price Target: $130 → $102
Current: $101.40
Upside: +0.59%
Jan 23, 2025
Maintains: Buy
Price Target: $285 → $260
Current: $157.65
Upside: +64.92%
Jan 23, 2025
Maintains: Hold
Price Target: $77 → $80
Current: $73.64
Upside: +8.64%
Aug 27, 2024
Initiates: Overweight
Price Target: $10
Current: $3.71
Upside: +169.54%
Feb 9, 2024
Downgrades: Hold
Price Target: $30 → $23
Current: $20.26
Upside: +13.52%
Jul 13, 2021
Initiates: Buy
Price Target: $13
Current: $1.98
Upside: +558.23%
Nov 2, 2017
Downgrades: Hold
Price Target: n/a
Current: $2.48
Upside: -
Oct 13, 2017
Maintains: Buy
Price Target: $9 → $11
Current: $1.77
Upside: +521.47%